364 related articles for article (PubMed ID: 8571669)
1. [Immune modulation by vitamin D analogs in the prevention of autoimmune diseases].
Bouillon R; Verstuyf A; Branisteanu D; Waer M; Mathieu C
Verh K Acad Geneeskd Belg; 1995; 57(5):371-85; discussion 385-7. PubMed ID: 8571669
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
4. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D physiology.
Lips P
Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
[TBL] [Abstract][Full Text] [Related]
6. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
7. [Vitamin D and the immune system].
Thomasset M
Pathol Biol (Paris); 1994 Feb; 42(2):163-72. PubMed ID: 8090562
[TBL] [Abstract][Full Text] [Related]
8. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D analogs: therapeutic applications and mechanisms for selectivity.
Brown AJ; Slatopolsky E
Mol Aspects Med; 2008 Dec; 29(6):433-52. PubMed ID: 18554710
[TBL] [Abstract][Full Text] [Related]
10. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings.
Verstuyf A; Verlinden L; Van Baelen H; Sabbe K; D'Hallewyn C; De Clercq P; Vandewalle M; Bouillon R
J Bone Miner Res; 1998 Apr; 13(4):549-58. PubMed ID: 9556055
[TBL] [Abstract][Full Text] [Related]
11. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
Barreto AM; Schwartz GG; Woodruff R; Cramer SD
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):265-70. PubMed ID: 10750664
[TBL] [Abstract][Full Text] [Related]
12. The immunological functions of the vitamin D endocrine system.
Hayes CE; Nashold FE; Spach KM; Pedersen LB
Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):277-300. PubMed ID: 12887108
[TBL] [Abstract][Full Text] [Related]
13. 1 alpha,25-(OH)2-vitamin D3 analogs with minimal in vivo calcemic activity can stimulate significant transepithelial calcium transport and mRNA expression in vitro.
Fleet JC; Bradley J; Reddy GS; Ray R; Wood RJ
Arch Biochem Biophys; 1996 May; 329(2):228-34. PubMed ID: 8638956
[TBL] [Abstract][Full Text] [Related]
14. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R
Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157
[TBL] [Abstract][Full Text] [Related]
15. Vitamins as hormones.
Reichrath J; Lehmann B; Carlberg C; Varani J; Zouboulis CC
Horm Metab Res; 2007 Feb; 39(2):71-84. PubMed ID: 17326003
[TBL] [Abstract][Full Text] [Related]
16. [Vitamin D].
Miyaura C; Suda T
Nihon Rinsho; 1993 Apr; 51(4):893-900. PubMed ID: 8483269
[TBL] [Abstract][Full Text] [Related]
17. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
[TBL] [Abstract][Full Text] [Related]
18. [1,25-dihydroxyvitamin D3: the endocrine system meets the immune system].
Mathieu C; Decallonne B; van Etten E
Verh K Acad Geneeskd Belg; 2002; 64(1):71-80; discussion 80-2. PubMed ID: 11995203
[TBL] [Abstract][Full Text] [Related]
19. The novel vitamin D analog ZK191784 as an intestine-specific vitamin D antagonist.
Nijenhuis T; van der Eerden BC; Zügel U; Steinmeyer A; Weinans H; Hoenderop JG; van Leeuwen JP; Bindels RJ
FASEB J; 2006 Oct; 20(12):2171-3. PubMed ID: 17012263
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
Bischof MG; Redlich K; Schiller C; Chirayath MV; Uskokovic M; Peterlik M; Cross HS
J Pharmacol Exp Ther; 1995 Dec; 275(3):1254-60. PubMed ID: 8531089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
